{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T22:45:08Z","timestamp":1771541108248,"version":"3.50.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Optometry - Journal of the American Optometric Association"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.optm.2005.12.002","type":"journal-article","created":{"date-parts":[[2006,2,15]],"date-time":"2006-02-15T12:21:06Z","timestamp":1140006066000},"page":"76-81","source":"Crossref","is-referenced-by-count":7,"title":["Acute onset of halos and glare: Bilateral corneal epithelial edema with cystic eruptions\u2014atypical presentation of amiodarone keratopathy"],"prefix":"10.1016","volume":"77","author":[{"given":"John M.","family":"Dovie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew S.","family":"Gurwood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.optm.2005.12.002_bib1","series-title":"Physicians\u2019 Desk Reference","first-page":"3487","author":"Murray","year":"2002"},{"issue":"9","key":"10.1016\/j.optm.2005.12.002_bib2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.7326\/0003-4819-122-9-199505010-00008","article-title":"Amiodarone","volume":"122","author":"Podrid","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.optm.2005.12.002_bib3","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1001\/jama.1990.03440180065033","article-title":"Treatment failure after substitution of generic pancrelipase capsules","volume":"263","author":"Hendeles","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.optm.2005.12.002_bib4","article-title":"Adverse effects and monitoring of long-term oral amiodarone administration in amiodarone","author":"Hilleman","year":"2000","journal-title":"American Council on Pharmaceutical Education"},{"key":"10.1016\/j.optm.2005.12.002_bib5","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1001\/archinte.1997.00440390066010","article-title":"A physician survey on generic drugs and substitution of critical dose mediations","volume":"157","author":"Banahan","year":"1997","journal-title":"Arch Intern Med"},{"issue":"8","key":"10.1016\/j.optm.2005.12.002_bib6","first-page":"1183","article-title":"Generic drug product equivalence","volume":"4","author":"Meyer","year":"1998","journal-title":"Am J Manag Care"},{"issue":"6 pt 2","key":"10.1016\/j.optm.2005.12.002_bib7","first-page":"138S","article-title":"Optimal management of amiodarone therapy","volume":"18","author":"Hilleman","year":"1998","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.optm.2005.12.002_bib8","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1001\/jama.258.9.1200","article-title":"Generic substitution","volume":"258","author":"Nightingale","year":"1987","journal-title":"JAMA"},{"key":"10.1016\/j.optm.2005.12.002_bib9","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1093\/ajhp\/56.7.615","article-title":"Transplant pharmacists\u2019 opinions on generic product selection of critical-dose drugs","volume":"1","author":"Vasquez","year":"1999","journal-title":"Am J Health Syst Pharm"},{"issue":"2","key":"10.1016\/j.optm.2005.12.002_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0272-6386(99)70318-5","article-title":"Drug substitution in transplantation","volume":"33","author":"Sabatini","year":"1999","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/j.optm.2005.12.002_bib11","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/j.1875-9114.1995.tb04379.x","article-title":"Bioequivalence and narrow therapeutic index drugs","volume":"15","author":"Benet","year":"1995","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.optm.2005.12.002_bib12","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1093\/ajhp\/54.14.1630","article-title":"FDA position on product selection for \u2018narrow therapeutics index\u2019 drugs","volume":"54","author":"Williams","year":"1997","journal-title":"Am J Health Syst Pharm"},{"issue":"9","key":"10.1016\/j.optm.2005.12.002_bib13","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1177\/153537020122600903","article-title":"Drug-induced phospholipidosis","volume":"226","author":"Reasor","year":"2001","journal-title":"Exp Biol Med"},{"issue":"5","key":"10.1016\/j.optm.2005.12.002_bib14","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1111\/j.1476-5381.1996.tb15747.x","article-title":"Inhibition by vitamin E of drug accumulation and of phospholipidosis induced by desipramine and other cationic amphiphilic drugs in human cultured cells","volume":"119","author":"Scuntaro","year":"1996","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.optm.2005.12.002_bib15","series-title":"Grayson\u2019s Diseases of the Cornea","first-page":"191","article-title":"Approach to Diseases of the Cornea","author":"Arffa","year":"1997"},{"key":"10.1016\/j.optm.2005.12.002_bib16","first-page":"49","article-title":"Drug-induced lysosomal storage disorders","volume":"Vol. 6","author":"L\u00fcllmann-Rauch","year":"1979"},{"issue":"2","key":"10.1016\/j.optm.2005.12.002_bib17","first-page":"113","article-title":"Visual changes secondary to initiation of amiodarone","volume":"73","author":"Castells","year":"2002","journal-title":"Optometry"},{"issue":"4","key":"10.1016\/j.optm.2005.12.002_bib18","first-page":"178","article-title":"Amiodarone-induced ultrastructural changes in human eyes","volume":"19","author":"Ghosh","year":"1984","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/j.optm.2005.12.002_bib19","first-page":"34","article-title":"Ocular complications from amiodarone","volume":"16","author":"Swann","year":"1999","journal-title":"Optometry Today"},{"issue":"4","key":"10.1016\/j.optm.2005.12.002_bib20","first-page":"231","article-title":"Optic nerve ultrastructure following amiodarone therapy","volume":"8","author":"Mansour","year":"1988","journal-title":"J Clin Neuroophthalmol"},{"key":"10.1016\/j.optm.2005.12.002_bib21","first-page":"20","article-title":"Toxicology of the Eye\u2014Part 1","volume":"224","author":"Lawrenson","year":"2002","journal-title":"Optician"},{"issue":"10","key":"10.1016\/j.optm.2005.12.002_bib22","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/S0161-6420(84)34165-3","article-title":"Clinical experience and grading of amiodarone keratopathy","volume":"91","author":"Orlando","year":"1984","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.optm.2005.12.002_bib23","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0039-6257(97)00118-5","article-title":"Ocular side effects of amiodarone","volume":"42","author":"Mantyjarvi","year":"1998","journal-title":"Surv Ophthalmol"},{"issue":"4 pt 2","key":"10.1016\/j.optm.2005.12.002_bib24","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/0002-8703(83)90014-5","article-title":"Ocular effects in long-term amiodarone therapy","volume":"106","author":"Ingram","year":"1983","journal-title":"Am Heart J"},{"key":"10.1016\/j.optm.2005.12.002_bib25","series-title":"Pharmacology Review Notes","first-page":"9","article-title":"Antiarrhythmic Agents","author":"Kolatkar","year":"1997"},{"issue":"3","key":"10.1016\/j.optm.2005.12.002_bib26","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1755-3768.1983.tb01447.x","article-title":"Amiodarone induced cornea verticillata","volume":"61","author":"Nielen","year":"1983","journal-title":"Acta Ophthalmol (Copenh)"},{"key":"10.1016\/j.optm.2005.12.002_bib27","series-title":"Confocal Microscopy of the Cornea","first-page":"47","article-title":"Corneal Microdeposits","author":"Mastropasqua","year":"2002"},{"issue":"4","key":"10.1016\/j.optm.2005.12.002_bib28","first-page":"243","article-title":"Confocal microscopic features of amiodarone keratopathy","volume":"22","author":"Yagmur","year":"2003","journal-title":"J Toxicol"},{"key":"10.1016\/j.optm.2005.12.002_bib29","article-title":"Amiodarone corneal topography","author":"Patalano","year":"2002","journal-title":"Dig J Ophthalmol"}],"container-title":["Optometry - Journal of the American Optometric Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183905003933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1529183905003933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,2,2]],"date-time":"2024-02-02T23:35:35Z","timestamp":1706916935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1529183905003933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S1529183905003933"],"URL":"https:\/\/doi.org\/10.1016\/j.optm.2005.12.002","relation":{},"ISSN":["1529-1839"],"issn-type":[{"value":"1529-1839","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]}}}